Qi Da1,2, Paul J Derry1,2, Fong W Lam1,3, Rolando E Rumbaut1,2. 1. Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, TX, USA. 2. Department of Medicine, Baylor College of Medicine, Houston, TX, USA. 3. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Abstract
OBJECTIVE: Monitoring endogenous platelets during intravital microscopy often involves two approaches: fluorescently labeled antibodies or genetic models of platelet-specific fluorescent protein expression. Due to limited data available on platelet functional changes induced by these methods, we compared functional effects of these methods on platelets. METHODS: Platelet aggregation to collagen and thrombin, and collagen matrix-mediated platelet adhesion/aggregation under flow were tested. We assessed platelets from mice expressing EYFP on platelets (Cre(+)), littermate controls (Cre(-)), C57BL/6 mice, and platelets from vehicle control and x-488 treatment. We utilized intravital microscopy to monitor platelets in vivo using Cre(+) mice and x-488 treatment. RESULTS: Both genetic and antibody-based approaches yielded substantial platelet-specific fluorescence. Platelets from Cre(+) and Cre(-) mice behaved similarly in aggregation and adhesion/aggregation under flow. However, they exhibited significantly enhanced aggregation and higher adhesion/aggregation as compared to platelets from C57BL/6 mice. Compared to vehicle control, x-488 platelet labeling did not induce significant functional changes in vitro. Both methods of platelet labeling provided satisfactory platelet detectability in vivo. CONCLUSIONS: x-488 antibody labeling of platelets induced less alteration of platelet function than genetic approaches under our experimental conditions and seems more suitable for monitoring of endogenous platelets. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
OBJECTIVE: Monitoring endogenous platelets during intravital microscopy often involves two approaches: fluorescently labeled antibodies or genetic models of platelet-specific fluorescent protein expression. Due to limited data available on platelet functional changes induced by these methods, we compared functional effects of these methods on platelets. METHODS:Platelet aggregation to collagen and thrombin, and collagen matrix-mediated platelet adhesion/aggregation under flow were tested. We assessed platelets from mice expressing EYFP on platelets (Cre(+)), littermate controls (Cre(-)), C57BL/6 mice, and platelets from vehicle control and x-488 treatment. We utilized intravital microscopy to monitor platelets in vivo using Cre(+) mice and x-488 treatment. RESULTS: Both genetic and antibody-based approaches yielded substantial platelet-specific fluorescence. Platelets from Cre(+) and Cre(-) mice behaved similarly in aggregation and adhesion/aggregation under flow. However, they exhibited significantly enhanced aggregation and higher adhesion/aggregation as compared to platelets from C57BL/6 mice. Compared to vehicle control, x-488 platelet labeling did not induce significant functional changes in vitro. Both methods of platelet labeling provided satisfactory platelet detectability in vivo. CONCLUSIONS:x-488 antibody labeling of platelets induced less alteration of platelet function than genetic approaches under our experimental conditions and seems more suitable for monitoring of endogenous platelets. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona Journal: Nat Methods Date: 2012-06-28 Impact factor: 28.547
Authors: Rolando E Rumbaut; Ricardo V Bellera; Jaspreet K Randhawa; Corie N Shrimpton; Swapan K Dasgupta; Jing-Fei Dong; Alan R Burns Journal: Am J Physiol Heart Circ Physiol Date: 2005-11-11 Impact factor: 4.733
Authors: S Reitsma; M G A Oude Egbrink; V V T Heijnen; R T A Megens; W Engels; H Vink; D W Slaaf; M A M J van Zandvoort Journal: Thromb Haemost Date: 2011-09-08 Impact factor: 5.249
Authors: Amir Mehdi Ansari; A Karim Ahmed; Aerielle E Matsangos; Frank Lay; Louis J Born; Guy Marti; John W Harmon; Zhaoli Sun Journal: Stem Cell Rev Rep Date: 2016-10 Impact factor: 5.739
Authors: Simon D J Calaminus; Amelie V Guitart; Amelie Guitart; Amy Sinclair; Hannah Schachtner; Steve P Watson; Tessa L Holyoake; Kamil R Kranc; Laura M Machesky Journal: PLoS One Date: 2012-12-27 Impact factor: 3.240
Authors: Zhao Shan; Leike Li; Constance Lynn Atkins; Meng Wang; Yankai Wen; Jongmin Jeong; Nicolas F Moreno; Dechun Feng; Xun Gui; Ningyan Zhang; Chun Geun Lee; Jack A Elias; William M Lee; Bin Gao; Fong Wilson Lam; Zhiqiang An; Cynthia Ju Journal: Elife Date: 2021-06-10 Impact factor: 8.140
Authors: Daniel DeHelian; Shuchi Gupta; Jie Wu; Chelsea Thorsheim; Brian Estevez; Matthew Cooper; Kelly Litts; Melissa M Lee-Sundlov; Karin M Hoffmeister; Mortimer Poncz; Peisong Ma; Lawrence F Brass Journal: Blood Date: 2020-10-08 Impact factor: 25.476